Ventricular Arrhythmias and Sudden Cardiac Death affairs... · Ventricular Arrhythmias and Sudden Cardiac Death Department of Cardiology, Arcispedale S. Anna University of Ferrara

Ventricular Arrhythmias and

Sudden Cardiac Death

Department of Cardiology,

Arcispedale S. Anna

University of Ferrara

Matteo Bertini, MD, PhD

No conflict of interest to

declare

One of the most common causes of death:

Sudden Cardiac Arrest Statistics

• High recurrence rate

• Last ESC guidelines 2006

<5%400,0003W. Europe

5%450,0002U.S.

<1%3,000,0001Worldwide

SurvivalIncidence(cases/year)

Priori et al Eur Heart J 2015

Structure of the guidelines

18 members of Task Force

• 14 sections

• 74 peer reviewers

• 810 references

• Guidelines reviewed concerning prevention of SCD are listed in Web Table

• Less than 5% of the patients will survive an episode of SCD

• The focus is on prevention! (for potential victims or family members!)

Cardiovascular Mortality: 17 million deaths every year in the world

SCD(25%)

Non SCD

Arrhythmia and SCD

Albert CM. Circulation. 2003;107:2096-2101.

12%Other Cardiac

Cause

88%Arrhythmic

Cause

Importance and relevance

The risk of SCD is:

1. higher in men than in women,

2. increases with age due to the higher prevalence of CAD in older age.

Importance and relevance

Cardiac diseases associated with SCD differ in young vs. older individuals

– Young: channelopathies, cardiomyopathies, myocarditis and substance abuse

– Older: chronic degenerative diseases, such as CAD, valvular heart diseases and HF, predominate.

What’s hot and what’s not …

• Not much new data in ICD and ischemic heart disease and HF, as no new trial has been performed

• Currently available anti-arrhythmic drugs have not been shown in RCTs, to be effective in primary management of patients with life-threatening VA or in prevention of SCD, while each drug has a significant potential for causing adverse events, including pro-arrhythmia.

What’s hot and what’s not …

• The screening of families in which there is a sudden death.

• For the first time, recommendations on the wearable and SICD.

• Good discussion on whether LBBB / non-LBBB morphologies are important discriminators or if the absolute QRS duration is most important.

– Recommendations on the use of CRT for the primary prevention of SCD are provided, according to the NYHA of the patient and the presence of sinus rhythm vs. atrial fibrillation.

• Sections on cardiomyopathies and channellopathies.

3.2 Indications for autopsy and

molecular autopsy in sudden death

victims

The Guidelines have a well developed section of screening of families in which there is a sudden death, as well as the workup of patients at high risk.

Indications for autopsy and molecular autopsy in sudden death victims are also detailed.

For 1st time- DNA analysis should be a fundamental component of post mortem assessment in SD victims, especially in young

Diagnostic workup in patients

presenting with

sustained VT or VF

4.3 DEVICE THERAPY

New!

6. Therapies for patients with left ventricular dysfunction with or without heart failure

6. Therapies for patients with left ventricular dysfunction with or without heart failure

CRT for prevention of SCD Recommendation Class I for• LVEF < 35%, • LBBB• QRS d > 120 ms.

Inherited primary arrhythmia syndromes

Inherited primary arrhythmia syndromes

14. To do and to not do messages from the guidelines

~ 50% of cardiac arrests occur in individuals without known heart disease

14. To do and to not do messages from the guidelines

Priori et al Eur Heart J doi:10.1093/eurheartj/ehv316

Thanks!